In a regulatory filing, Jabil (JBL) director Christopher Holland disclosed the sale of 3,400 common shares of the company on January 31 at a ...

The deal complements Jabil’s specialty in injectable drug delivery systems, like those used for popular GLP-1 diabetes drugs ...

In a report released on January 24, Samik Chatterjee from J.P. Morgan maintained a Buy rating on Jabil (JBL – Research Report), with a price ...

Jabil's diversification in end markets, particularly Auto & Transportation and Healthcare & Packaging, is driving revenue ...

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

Jabil Inc. closed 7.48% below its 52-week high of $174.80, which the company reached on January 24th.

The institutional investor owned 1,854 shares of the technology company’s stock after selling 4,476 shares during the quarter. SG Americas Securities LLC’s holdings in Jabil were worth $ ...

For superior performance in quality, delivery, innovation and partnership related to fluid dispensing systems used in ...

The stock's fall snapped an eight-day winning streak.

The manufacturer has been exploring a sale since 2023. STORY HIGHLIGHTS Jabil Inc. acquired Pharmaceutics International Inc. on Feb. 3. Pharmaceutics operates a 360,000-square-foot campus in Hunt ...